JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 3, 2005; DOI: 10.1124/jpet.105.089052


0022-3565/05/3143-1013-1022$20.00
JPET 314:1013-1022, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.089052v1
314/3/1013    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kazerounian, S.
Right arrow Articles by Waldman, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kazerounian, S.
Right arrow Articles by Waldman, S. A.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Proliferative Signaling by Store-Operated Calcium Channels Opposes Colon Cancer Cell Cytostasis Induced by Bacterial Enterotoxins

Shiva Kazerounian, Giovanni M. Pitari, Fawad J. Shah, Glen S. Frick, Muniswamy Madesh, Inez Ruiz-Stewart, Stephanie Schulz, Gyorgy Hajnóczky, and Scott A. Waldman

Division of Clinical Pharmacology, Departments of Medicine and Biochemistry and Molecular Pharmacology (S.K., G.M.P., F.J.S., G.S.F., I.R.-S., S.S., S.A.W.), and Department of Pathology, Anatomy and Cell Biology (M.M., G.H.), Thomas Jefferson University, Philadelphia, Pennsylvania

Received May 3, 2005; accepted June 1, 2005.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Guanylyl cyclase C and accumulation of cGMP induced by bacterial heat-stable enterotoxins (STs) promote colon cancer cell cytostasis, serving as a tumor suppressor in intestine. Conversely, capacitative calcium entry through store-operated calcium channels (SOCs) is a key signaling mechanism that promotes colon cancer cell proliferation. The present study revealed that proliferative signaling by capacitative calcium entry through SOCs opposes and is reciprocally coupled to cytostasis mediated by guanylyl cyclase C in T84 human colon carcinoma cells. Elimination of capacitative calcium entry employing 2-aminoethoxydiphenylborate (2-APB), a selective inhibitor of SOCs, potentiated cytostasis induced by ST. Opposition of ST-induced cytostasis by capacitative calcium entry reflects reciprocal inhibition of guanylyl cyclase C signaling. Calcium entry through SOCs induced by the calcium-ATPase inhibitor thapsigargin or the receptor agonists UTP or carbachol inhibited guanylyl cyclase C-dependent cGMP accumulation. This effect was mimicked by the calcium ionophore ionomycin and blocked by 2-APB and intracellular 1,2-bis(o-amino-5,5'-dibromophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester (BAPTA-AM), a chelator of calcium. Moreover, regulation by capacitative calcium entry reflected ligand-dependent sensitization of guanylyl cyclase C to inhibition by that cation. Although basal catalytic activity was refractory, ST-stimulated guanylyl cyclase C was inhibited by calcium, which antagonized binding of magnesium to allosteric sites required for receptor-effector coupling. These observations demonstrate that reciprocal regulation of guanylyl cyclase C signaling by capacitative calcium entry through SOCs represents one limb of a coordinated mechanism balancing colon cancer cell proliferation and cytostasis. They suggest that combining guanylyl cyclase C agonists and SOC inhibitors offers a novel paradigm for cGMP-directed therapy and prevention for colorectal tumors.


Other than tobacco-related tumors, colorectal cancer is the leading cause of cancer and cancer-related mortality in the world, with a geographic distribution primarily affecting patients in developed countries (Ferlay et al., 2001Go). Although the epidemiology of this disease remains poorly understood, there is an unexplained inverse relationship between the incidence of colorectal cancer and enterotoxigenic Escherichia coli (ETEC) infections (Ferlay et al., 2001Go). ETEC produces heat-stable enterotoxins (STs), a principle cause of secretory diarrhea in endemic populations, travelers, and agriculturally important animal herds (Thielman and Guerrant, 2004Go). These enterotoxins are plasmid-encoded small (≤19 amino acids) peptides that bind to guanylyl cyclase C specifically expressed in intestinal epithelial cells (Lucas et al., 2000Go). Association of STs with the extracellular domain of guanylyl cyclase C activates the intracellular catalytic domain that converts GTP into cGMP. The second messenger cGMP, in turn, activates cGMP-dependent protein kinase II, which ultimately activates the cystic fibrosis transmembrane conductance regulator, a chloride channel, resulting in secretory diarrhea.

Beyond volume homeostasis, guanylyl cyclase C suppresses the proliferation of human colon carcinoma cells (Pitari et al., 2001Go, 2003Go) and the development of hyperproliferative adenoma in mouse models of intestinal neoplasia (Shailubhai et al., 2000Go). Moreover, the expression of the endogenous guanylyl cyclase C ligands guanylin and uroguanylin is invariably lost during tumor progression, and this loss of function represents one key mutational event underlying proliferation associated with carcinogenesis in the colon (Cohen et al., 1998Go; Shailubhai et al., 2000Go; Pitari et al., 2001Go, 2003Go; Steinbrecher et al., 2002Go). Similar to secretion, the suppression of colon cancer cell proliferation by guanylyl cyclase C is mediated by cGMP (Pitari et al., 2001Go, 2003Go). However, in contrast to volume homeostasis, the antiproliferative signal initiated by cGMP is propagated by Ca2+ influx through cyclic nucleotide-gated (CNG) channels (Pitari et al., 2003Go). This role for guanylyl cyclase C as a tumor suppressor likely contributes to the inverse association between colorectal cancer and ETEC infections (Shailubhai et al., 2000Go; Ferlay et al., 2001Go; Pitari et al., 2001Go, 2003Go), reflecting in part the longitudinal exposure to ST-producing bacteria in underdeveloped countries.

Whereas Ca2+ influx through CNG channels suppresses colon cancer cell proliferation (Pitari et al., 2001Go, 2003Go), Ca2+ also is a critical signaling element required for cell proliferation (Weiss et al., 2001Go), controlling gene expression, progression through the cell cycle, and DNA synthesis (Berridge et al., 1998Go). Additionally, Ca2+ plays a central role in signaling cascades that drive tumorigenesis and neoplastic progression (Cole and Kohn, 1994Go; Berridge et al., 1998Go) and inhibitors of Ca2+-dependent signaling suppress proliferation of cancer cells in vitro and in solid tumors in vivo (Cole and Kohn, 1994Go; Holmuhamedov et al., 2002Go). One source of Ca2+ that promotes proliferation is capacitative entry from the extracellular pool through store-operated Ca2+ channels (SOCs) (Golovina et al., 2001Go; Peng et al., 2003Go). In human colon cancer cells, capacitative Ca2+ entry through SOCs is required to support proliferation (Weiss et al., 2001Go; Peng et al., 2003Go).

Thus, capacitative Ca2+ entry through SOCs and guanylyl cyclase C-mediated cGMP production represent opposing limbs of a signaling system that regulates colon cancer cell proliferation. This is one example of a paradigm in which Ca2+ and cGMP mediate opposing (patho)physiological processes, including smooth muscle contractility, platelet aggregation, endocrine secretion, and visual phototransduction (Sargeant and Sage, 1994Go; Lucas et al., 2000Go; Andric et al., 2001Go). A hallmark of systems regulated by opposing Ca2+ and cGMP signals is the reciprocal regulation of their intracellular concentrations (Lucas et al., 2000Go). Molecular mechanisms that regulate intracellular [Ca2+] ([Ca2+]i) by cGMP are well described (Rink and Merritt, 1990Go; Sargeant and Sage, 1994Go; Berridge et al., 1998Go). In contrast, those by which Ca2+ regulates intracellular [cGMP] ([cGMP]i) have only recently been explored (Lucas et al., 2000Go; Andric et al., 2001Go; Kazerounian et al., 2002Go). Here, we demonstrate that capacitative Ca2+ entry through SOCs promotes the proliferation of and reciprocally inhibits guanylyl cyclase C-dependent antiproliferative signaling in human colon carcinoma cells. Reciprocal regulation of cGMP-dependent antiproliferative signaling reflects the ability of guanylyl cyclase C to serve as a functional sensor for Ca2+, which is conditionally coupled to allosteric inhibition of the catalytic domain by ligand activation.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Materials. Dulbecco's modified Eagle's/Ham's F-12 medium (50/50 mixture), Ca2+-free minimal essential medium, and fetal bovine serum were purchased from Mediatech (Herndon, VA). ST was prepared by solid-phase synthesis and purified by reverse-phase high-performance liquid chromatography, structures were confirmed by mass spectrometry, and activities were confirmed by analysis of guanylyl cyclase C receptor binding and catalytic activation. Poly-D-lysine hydrobromide was obtained from BD Biosciences Discovery Labware (Bedford, MA). BAPTA-AM and Fura-2-AM were obtained from Molecular Probes (Eugene, OR). Fura-2/free acid was obtained from Teflabs (Austin, TX). Thapsigargin, ionomycin, carbachol, and 2-aminoethoxydiphenylborate (2-APB) were obtained from Calbiochem (San Diego, CA). Isobutylmethylxanthine (IBMX), dithiothreitol, phenylmethanesulfonyl fluoride, UTP, EGTA, GTP, and EDTA were purchased from Sigma-Aldrich (St. Louis, MO). Protein was quantified using the Bradford method (Bio-Rad, Hercules, CA). All other reagents were from Fisher Scientific (Pittsburgh, PA).

Cells. T84 human colon carcinoma cells were obtained from the American Type Culture Collection (Manassas, VA) and grown in Dulbecco's modified Eagle's/Ham's F-12 medium with 10% (v/v) fetal bovine serum (BioWhittaker, Walkersville, MD), 2.5 mM glutamine, 100 units/ml penicillin, and 100 ug/ml streptomycin (BioWhittaker) in a humidified atmosphere of 5% CO2, unless otherwise indicated. Cells were fed with fresh medium every second day and split when subconfluent. Cells were employed for experiments at passages 10 through 40 after acquisition.

Preparation of Cell Membranes. T84 cell membranes were prepared as described previously (Parkinson and Waldman, 1996Go). Confluent cells in 75-cm2 cell culture flasks were homogenized in 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, and 1 mM phenylmethanesulfonyl fluoride (TEED buffer) and centrifuged at 100,000g for 60 min at 4°C. Resulting pellets were washed once with TEED containing 1 mM EGTA and twice with TEED containing 100 µM EGTA to remove adventitial Ca2+. Pellets were resuspended in TEED containing 100 µM EGTA at 2 mg protein/ml and stored at 4°C.

Guanylyl Cyclase. Guanylyl cyclase activity was quantified as described previously (Kazerounian et al., 2002Go). Briefly, 20 µg of membrane proteins was incubated for 5 min at 37°C in 100 µl of 50 mM Tris buffer, pH 7.5, which contained 500 µM IBMX, 15 mM creatine phosphate, 2.7 units of creatine phosphokinase, 1 mM Mg-GTP or MnGTP with 3 mM MgCl2 or MnCl2 in excess of nucleotide (unless otherwise indicated) in the presence or absence of 1 µM ST, and different concentrations of free Ca2+. In these studies, 1 µM ST was used since it is the concentration that produces maximum stimulation of guanylyl cyclase activity in intestinal cell membranes (Parkinson and Waldman, 1996Go; Pitari et al., 2001Go, 2003Go). Specific free Ca2+ and Mg2+ concentrations, buffered with 100 µM EGTA, were quantified employing the WinMax computer program (Kazerounian et al., 2002Go). In studies in which the free Mg2+ concentration was varied, total Mg2+ concentrations were always maintained above the free Ca2+ concentration (250 µM) to prevent Ca2+ chelation of GTP from becoming rate-limiting. Incubations at 37°C were initiated by the addition of enzyme, continued for 5 min, and terminated by adding 400 µl of 50 mM sodium acetate (pH 4.0) and boiling for 3 min. Enzyme activity was linear with respect to time and protein concentration under all conditions examined. Enzyme assays were performed in duplicate, and cGMP was quantified by radioimmunoassay in triplicate (Kazerounian et al., 2002Go). Analyses of enzyme kinetics were performed using Prism (GraphPad Software Inc., San Diego, CA) or Microsoft Excel (Microsoft, Redmond, WA).

Receptor Binding. Iodination of ST was performed as described previously (Hugues et al., 1991Go). T84 cell membranes (40 µg) were incubated with 100 pM 125I-ST in binding buffer containing 50 mM Tris-HCl, pH 7.6, 0.66 mM cystamine, 0.1% bacitracin, 450 mM NaCl, and 1 mM EDTA and incubated at 37°C for 120 min in the presence or absence of 1 µM excess of unlabeled ST. Free and membrane-associated radioactivity were separated by vacuum filtration employing Whatman GF/B glass microfiber filters (Whatman, Hillsboro, OR) presoaked in 0.3% polyethyleneimine. After applying samples, filters were washed three times with 5 ml of washing buffer (150 mM NaCl, 20 mM Na3PO4, pH 7.2, and 1 mM EDTA) to remove excess of unbound radioactivity. Radioactivity on filters was quantified in a Cobra II Gamma Counter (PerkinElmer Life and Analytical Sciences, Boston, MA).

Cyclic GMP Accumulation. Confluent T84 cells in 24-well plates were washed twice with 500 µl of Ca2+-free buffer containing 121 mM NaCl, 5 mM NaHCO3, 10 mM Na-HEPES, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM Mg2SO4, 10 mM D-glucose, and 0.25% bovine serum albumin, pH 7.4, preincubated in the same buffer containing 1 mM IBMX for 30 min, and then treated in duplicate with ST and the indicated agents for an additional 10 min. Reactions were terminated by adding 500 µl of ice-cold 100% ethanol, each well was washed with 200 µl of ice-cold 100% ethanol, and resultant extracts were centrifuged at 12,000g x 15 min at 4°C. Supernates containing cGMP were evaporated in a Savant SVC-100H concentrator (Thermo Electron Corporation, Waltham, MA) and reconstituted with 50 mM sodium acetate, pH 4.0, and cGMP was quantified in each sample in triplicate by radioimmunoassay (Kazerounian et al., 2002Go).

Cell Proliferation. Exponentially growing cells (~70% confluent in 96-well/plates) were synchronized by serum starvation in Eagle's minimal essential medium for 48 h. In some incubations, proliferation was induced with 10 mM glutamine (Pitari et al., 2001Go) in Ca2+-free minimal essential medium containing experimental agents as indicated, and incubations continued for 24 h. Cell proliferation was quantified by cell number or [3H]thymidine incorporation into DNA after the addition of 0.2 µCi/well [methyl-3H]thymidine for the final 3 h (Pitari et al., 2001Go, 2003Go).

Fluorescence Calcium Imaging. T84 cells were plated on poly-D-lysine-coated coverslips at a density of 25,000 to 30,000 cells/cm2 and grown for 3 to 4 days to form a monolayer. Cells were incubated for 20 min at 37°C in extracellular buffer containing 121 mM NaCl, 5 mM NaHCO3, 10 mM Na-HEPES, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM Mg2SO4, 2 mM CaCl2, 10 mM D-glucose, and 2% bovine serum albumin, pH 7.4, and then loaded with 5 µM Fura-2-AM in the presence of 200 µM sulfinpyrazone and 0.003% (w/v) pluronic acid for 30 min at 37°C. Sulfinpyrazone also was present during imaging measurements to minimize dye loss. Cells were then washed once with extracellular buffer containing 2 mM CaCl2 and 2% bovine serum albumin and twice with Ca2+-free extracellular buffer containing 0.25% bovine serum albumin. Imaging measurements were performed in Ca2+-free extracellular buffer containing 0.25% bovine serum albumin at 35°C. The coverslip was placed on an open slide chamber (Harvard Apparatus, Holliston, MA) mounted on the stage of an Olympus IX70 inverted microscope fitted with a 40x (UApo, numerical aperture 1.35; Olympus, Tokyo, Japan) oil-immersion objective camera (NU 200; Photometrics, Tucson, AZ) under computer control and a light source. Fura-2-loaded cells were alternately excited at 340 and 380 nm using a motorized digitally controlled filter wheel (Ludl Electronic Products Ltd., Hawthorne, NY). Fluorescence emissions at 510 nm were collected with a cooled CCD 12-bit digital camera (PXL; Photometrics), and images were analyzed using customized software (Csordas and Hajnoczky, 2001Go).

Fluorescent signals determined from regions of interest were employed to calculate Ca2+ concentrations using an in vitro calibration method (Szalai et al., 1999Go). In vitro calibration was performed in intracellular medium containing 120 mM KCl, 10 mM NaCl, 1 mM KH2PO4, and 20 mM Tris-HEPES at pH 7.2 with 2 mM MgATP and 150 mM KOH in the presence of 5 µM Fura-2/free acid (Szalai et al., 1999Go). [Ca2+]i was quantified by the following equation (eq. 1):

(1)
where Kd is the dissociation constant 224 nM for Fura-2; Rmin and Rmax are the 340/380 ratios of the Ca2+-free form in the presence of 10 mM EGTA (pH 8.5) and Ca2+-bound form in the presence of 1.5 mM CaCl2, respectively; and b is the ratio of fluorescence excitation intensities of the two latter forms at 380 nm. Net [Ca2+]i was measured using the area under the curve of the specific region of interest and indicates the integration of the rise in [Ca2+]i above baseline, employing Prism (GraphPad Software Inc.). Experiments were performed at least three times, and 10 to 40 cells were monitored in each experiment. Traces represent the average of cell responses monitored on one coverslip.

Statistics. Results represent at least three separate experiments. Statistical significance was determined using paired Student's t tests (two-tailed) employing Microsoft Excel.


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
SOCs and Guanylyl Cyclase C Mediate Opposing Ca2+-Dependent Mechanisms Regulating Human Colon Cancer Cell Proliferation. Proliferation of cells, including human colon carcinoma cells, is critically dependent upon the dynamics of [Ca2+]i shaped, in part, through SOCs (Berridge et al., 1998Go; Weiss et al., 2001Go). Here, glutamine-induced proliferation of T84 human colon carcinoma cells, quantified by cell number (Fig. 1A) or thymidine incorporation (Fig. 1B), required extracellular Ca2+ (Fig. 1, A and B). Stimulation of T84 cell proliferation by extracellular Ca2+ was abrogated by 2-APB, a selective inhibitor of SOCs (Fig. 1, C and D) (Bootman et al., 2002Go). Alterations of T84 cell proliferation by 2-APB reflected inhibition of capacitative Ca2+ entry, since 2-APB was without effect on the release of Ca2+ from intracellular stores (Fig. 1E) (Ma et al., 2000Go). In contrast, signaling by guanylyl cyclase C mediates cytostasis of human colon carcinoma cells by inducing cGMP-dependent opening of cyclic nucleotide-gated channels and influx of extracellular calcium (Pitari et al., 2001Go, 2003Go). Indeed, the specific guanylyl cyclase C ligand ST inhibited T84 cell proliferation in a time-dependent fashion (Fig. 2A). ST-induced cytostasis of T84 cells was blocked by eliminating Ca2+ from the media and by L-cis-diltiazem, a selective inhibitor of cyclic nucleotide-gated channels (Fig. 2B). It is significant that the inhibition of SOCs by 2-ABP remarkably potentiated the antiproliferative effects of ST in a concentration-dependent fashion (Fig. 2C). These observations suggest that capacitative Ca2+ entry through SOCs, which is required for T84 cell proliferation, tonically opposes cytostasis induced by guanylyl cyclase C signaling.



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1. T84 cells require capacitative Ca2+ entry through SOCs to sustain proliferation. A–D, T84 cells were synchronized in Eagle's minimal essential medium as described under Materials and Methods and induced to proliferate for 24 h with 10 mM glutamine in media containing, where indicated, 100 µM 2-APB and/or 2 mM Ca2+, and proliferation was quantified by cell count (A and C) or [3H]thymidine incorporation into DNA (B and D). Ca2+ was required to support proliferation above baseline, quantified by cell count (A) or [3H]thymidine incorporation into DNA (B). *, p < 0.05 compared with incubations without Ca2+. This effect was mediated by capacitative entry, since 2-APB eliminated the effect of Ca2+ on proliferation (C and D). *, p < 0.05 compared with incubations without 2-APB. E, this effect of 2-APB reflected inhibition of SOCs rather than inhibition of Ca2+ release from intracellular stores. Indeed, 2-APB did not inhibit the ability of thapsigargin to induce intracellular Ca2+ release in T84 cells. Ca2+ release from intracellular stores was evoked with 1 µM thapsigargin in Ca2+-free buffer, and [Ca2+]i was quantified as described under Materials and Methods. Results are the means ± S.E.M. of ≥3 experiments performed in triplicate.

 


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2. Capacitative Ca2+ entry through SOCs opposes cytostasis induced by guanylyl cyclase C signaling in T84 cells. T84 cells, synchronized as described under Materials and Methods, were induced to proliferate with 10 mM glutamine in media containing, where indicated, 50 or 100 µM 2-APB, 2 mM Ca2+, and/or 1 µM ST, and proliferation was quantified by [3H]thymidine incorporation into DNA. A, ST inhibited T84 cell proliferation in a time-dependent fashion. *, p ≤ 0.05; **, p ≤ 0.01 compared with proliferation obtained in incubations with ST for 12 h. B, cytostatic effect of ST at 48 h is mediated by the influx of extracellular Ca2+ through CNG channels, since elimination of extracellular Ca2+ [(–)Ca2+] from the media or L-cis-diltiazem (L-DLT) blocked the effect of ST on T84 cell proliferation. *, p < 0.01 compared with control incubations containing 2 mM Ca2+. C, capacitative Ca2+ entry through SOCs opposes cytostasis induced by guanylyl cyclase C signaling in T84 cells. Incubation of T84 cells with ST for 12 h was without significant effect on proliferation (control; see also A). However, 2-APB in a concentration-dependent fashion unmasked a previously unrecognized effect of cytostasis by ST at 12 h. Inhibition of T84 cell proliferation specifically by ST was calculated as [(proliferation in the presence of 1 µM ST + the indicated concentration of 2-ABP)/(proliferation in the presence of the indicated concentration of 2-ABP)] x 100. *, p < 0.01 compared with control incubations containing the indicated concentrations of 2-APB but not ST.

 
Capacitative Calcium Entry through SOCs Opposes Cytostasis by Preventing Activation of Guanylyl Cyclase C Signaling by ST. Opposing guanylyl cyclase- and Ca2+-dependent processes are coordinated, in part, by reciprocal regulation of intracellular concentrations of these signaling molecules (Lucas et al., 2000Go; Andric et al., 2001Go; Kazerounian et al., 2002Go). Here, regulation of guanylyl cyclase C signaling by Ca2+ influx through SOCs was explored. Thapsigargin, which inhibits the Ca2+-ATPase in the endoplasmic reticulum, increases [Ca2+]i by preventing its intracellular sequestration (Thastrup et al., 1989Go). In turn, depletion of intracellular Ca2+ stores by thapsigargin opens SOCs, permitting capacitative Ca2+ entry (Parekh and Penner, 1997Go). In Ca2+-free media, thapsigargin induced a transient increase in [Ca2+]i in T84 cells originating from intracellular stores (Fig. 3A) without altering accumulation of [cGMP]i induced by ST (Fig. 3B). In the absence of thapsigargin and the associated opening of SOCs, 10 mM extracellular Ca2+ did not alter [Ca2+]i (Fig. 3A) or the accumulation of [cGMP]i induced by ST (data not shown). In contrast, in media containing Ca2+, thapsigargin produced a sustained elevation in [Ca2+]i (Fig. 3A) and inhibited accumulation of [cGMP]i induced by ST (Fig. 3C). Indeed, in the presence of thapsigargin, increasing [Ca2+]ext coordinately elevated [Ca2+]i and inhibited ST-induced [cGMP]i accumulation with an EC50 of 1.1 ± 0.7 mM (Fig. 3, D and E). In this context, the steady-state concentrations of [Ca2+]ext in intestine (1–20 mM) underscore the physiological significance of reciprocal inhibition of guanylyl cyclase C signaling by capacitative Ca2+ entry through SOCs (Welberg et al., 1993Go; Whitfield et al., 1995Go). BAPTA-AM, a chelator of Ca2+ that can be loaded intracellularly, reversed the inhibition of ST-induced [cGMP]i accumulation by thapsigargin and extracellular Ca2+ (Fig. 3C). Similarly, 2-APB prevented elevations in [Ca2+]i (Fig. 4, A–C) and reversed the inhibition of ST-induced [cGMP]i accumulation mediated by thapsigargin and extracellular Ca2+ (Fig. 4D). Furthermore, UTP and carbachol deplete intracellular Ca2+ stores and increase capacitative Ca2+ entry through G protein-dependent production of inositol polyphosphates mediated by P2Y purinergic and muscarinic receptors, respectively (Fig. 5, A and B) (Luo et al., 2001Go). Capacitative Ca2+ entry induced by UTP and carbachol mimicked the effects of thapsigargin, inhibiting [cGMP]i accumulation induced by ST (Fig. 5C). Moreover, ionomycin, a Ca2+ ionophore that directly increases [Ca2+]i (Fig. 5, A and B) (Liu and Hermann, 1978Go), mimicked the ability of UTP, carbachol, and thapsigargin to elevate [Ca2+]i and inhibit [cGMP]i accumulation induced by ST (Fig. 4, B and C). Thus, opposition of ST-dependent cytostasis by SOCs reflects inhibition of guanylyl cyclase C signaling by capacitative Ca2+ entry required for proliferation.



View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3. Thapsigargin-induced increases in [Ca2+]i inhibit ST-stimulated guanylyl cyclase C in T84 cells. A, thapsigargin produced sustained increases in [Ca2+]i by inducing influx of extracellular Ca2+ in T84 cells. [Ca2+]i was quantified in Fura-2-loaded T84 cells as described under Materials and Methods. Ca2+ entry was evoked by depleting [Ca2+]i stores with 1 µM thapsigargin in Ca2+-free buffer at 1.5 min. At 15 min, the addition of 1 µM ST and 5 mM [Ca2+]ext was associated with a rise in [Ca2+]i (arrow). B and C, thapsigargin (Thap) inhibited ST-stimulated [cGMP]i accumulation in media containing 5 mM Ca2+ (C) but not in Ca2+-free media (B). In addition, BAPTA-AM, a chelator of [Ca2+]i, prevented thapsigargin-induced inhibition of guanylyl cyclase C signaling in T84 cells in media containing 5 mM Ca2+ (C). T84 cells were incubated with 20 µM BAPTA-AM for 60 min before treating cells with thapsigargin, Ca2+, and ST as outlined in A. Results are the means ± S.E.M of more than three experiments performed in duplicate. *, p < 0.05 compared with incubations without thapsigargin (Con, control). D, elevations in [Ca2+]i produced by thapsigargin were dependent on the [Ca2+]ext. Ca2+ entry, evoked as outlined in A employing increasing (10–4-10–2 mM) [Ca2]ext, was associated with a concentration-dependent increase in [Ca2+]i (arrow). Results represent 1 of ≥3 independent experiments. E, changes in net [Ca2+]i ({blacksquare}) and inhibition of [cGMP]i production ({diamond}) in response to increasing [Ca2+]ext. Net [Ca2+]i represents the integration of increases in [Ca2+]i above baseline between 15 and 25 min (area under the curve), as outlined under Materials and Methods. Results are the means ± S.E.M. from ~30 cells in one representative of ≥3 experiments. *, p < 0.05 compared with incubations without Ca2+.

 


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 4. Capacitative Ca2+ entry through SOCs inhibits guanylyl cyclase C. A–C, 2-APB prevented increases in [Ca2+]i produced by thapsigargin. T84 cells were loaded with Fura-2 and, where indicated, 100 µM 2-APB, and changes in [Ca2+]i were quantified (A) and imaged (B) as described under Materials and Methods. Results in C are means ± S.E.M. from 35 cells with 2-APB and 19 cells without 2-APB from one representative of ≥3 experiments. D, 2-APB blocks thapsigargin-dependent inhibition of ST-stimulated guanylyl cyclase C in T84 cells. Cyclic GMP production was quantified as described under Materials and Methods. Results are means ± S.E.M. of one representative of ≥3 experiments performed in duplicate. *, p < 0.05 compared with incubations conducted without 2-APB.

 


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5. Heterologous desensitization of ST-stimulated guanylyl cyclase C by G protein-coupled receptor-dependent capacitative Ca2+ entry. A, UTP and carbachol increased [Ca2+]i in T84 cells by receptor-mediated activation of capacitative Ca2+ entry. T84 cells loaded with Fura-2 were incubated with 10 µM ionomycin, 100 µM UTP, or 100 µM carbachol, and changes in [Ca2+]i were quantified as described under Materials and Methods. B, UTP and carbachol (Carb) produced increases in net [Ca2+]i that were comparable to those produced by thapsigargin (Thap) but lower than those produced by ionomycin (Iono). Concomitantly, UTP and carbachol produced reductions in ST-induced guanylyl cyclase C activation that were comparable to those produced by thapsigargin but lower than those produced by ionomycin (C). Cyclic GMP production was quantified in experiments in C as described under Materials and Methods. Changes in net [Ca2+]i and ST-induced cGMP accumulation produced by thapsigargin were calculated from data presented in Fig. 3. Results are means ± S.E.M. of ≥3 experiments performed in duplicate. *, p < 0.05 compared with control incubations without ionomycin, UTP, carbachol, or thapsigargin.

 

Opposition of ST-Induced Signaling by Capacitative Ca2+ Entry Reflects Conditional Sensitization of Guanylyl Cyclase C to Ca2+ Inhibition by Ligand Activation. Whereas mechanisms reciprocally regulating [Ca2+]i and [cGMP]i remain incompletely defined, an emerging paradigm suggests that guanylyl cyclases are conditional sensors of Ca2+, which allosterically inhibits the ligand-activated conformation (Lucas et al., 2000Go; Kazerounian et al., 2002Go). Here, Ca2+ inhibited ST-stimulated but not basal guanylyl cyclase C in T84 cell membranes when Mg2+ (Fig. 6, A and C) but not Mn2+ (Fig. 6B) served as the cation cofactor. In contrast, Ca2+ did not support basal or ligand-stimulated guanylyl cyclase C activity (data not shown). Ca2+ inhibited ST-stimulated guanylyl cyclase C in a concentration-dependent fashion, with a Ki of ~10–5 M (Fig. 6D). It is noteworthy that the potency of Ca2+ to inhibit guanylyl cyclase C signaling in cell-free membranes was nearly identical to that observed in intact cells employing physiological [Ca2+]ext characteristics of intestine (Fig. 3, D and E) (Welberg et al., 1993Go; Whitfield et al., 1995Go). Inhibition of guanylyl cyclase C by Ca2+ did not reflect interference with ligand-receptor interaction (Fig. 7A) or receptor-effector coupling (Fig. 7B; Table 1). Rather, the Ka of ST for activating guanylyl cyclase C in the presence of Ca2+ was lower than in its absence, consistent with enhanced receptor-effector coupling (Table 1). It is significant that Ca2+ decreased the Km and Vmax of ST-activated guanylyl cyclase C, characteristics of an uncompetitive allosteric mechanism (Fig. 7; Table 2). Indeed, Ca2+ inhibited guanylyl cyclase C by competitive antagonism of free Mg2+ binding to divalent cation sites required for ligand activation (Fig. 8; Table 3). Thus, in human colon cancer cells, cytostatic signaling by ST serves as a switch that conditionally sensitizes guanylyl cyclase C to reciprocal inhibition by capacitative Ca2+ entry conducted by SOCs central to mitogenesis.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 6. Guanylyl cyclase C is conditionally sensitized to Ca2+ inhibition by ligand activation. Guanylyl cyclase C activity in T84 cell membranes was quantified as described under Materials and Methods in incubations containing 1 mM Mg-GTP and 3 mM excess free Mg2+ (A); 1 mM Mn-GTP, 3 mM excess free Mn2+, and 1 µM ST (B); 1 mM Mg-GTP, 3 mM excess free Mg2+, and 1 µM ST (C). D, relationship between inhibition of guanylyl cyclase C and the concentration of Ca2+. The activity of guanylyl cyclase C in T84 cell membranes was quantified in incubations containing 1 µM ST, Ca2+ (10–6-10–3 M), 1 mM Mg-GTP, and 3 mM excess Mg2+. The maximum velocity (fractional velocity = 1) reflected the velocity quantified in the absence of Ca2+. Data presented in D were subjected to double reciprocal analysis (inset). Results represent ≥3 experiments performed in duplicate, with each sample analyzed in triplicate. *, p < 0.05 compared with incubations without Ca2+.

 


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 7. Ca2+ inhibits guanylyl cyclase C by an uncompetitive kinetic mechanism. A, Ca2+ does not alter binding of ST to guanylyl cyclase C. The binding of 125I-ST to T84 cell membrane was quantified as described under Materials and Methods in incubations containing Ca2+ (0.1–10 mM) where indicated. B, Ca2+ does not alter guanylyl cyclase C receptor-effector coupling. Guanylyl cyclase C activity in T84 cell membranes was quantified in incubations containing 1 mM Mg-GTP, 3 mM excess Mg2+, and ST (10–10-10–6 M) in the absence ({bullet}) or presence ({blacktriangleup}) of 1 mM Ca2+. Data presented in B were subjected to double reciprocal analysis (inset). C, Ca2+ inhibits guanylyl cyclase C by an uncompetitive kinetic mechanism. Guanylyl cyclase C activity in T84 cell membranes was quantified in incubations containing 1 µM ST, Mg-GTP (0.1–10 mM), and 3 mM excess Mg2+ in the absence ({bullet}) or presence ({blacktriangleup}) of 1 mM Ca2+. Data presented in C were subjected to double reciprocal analysis (D). Results represent three experiments performed in duplicate, with each sample analyzed in triplicate.

 

View this table:
[in this window]
[in a new window]
 
TABLE 1 Calcium inhibits guanylyl cyclase C stimulated by ST

Maximum ST-induced guanylyl cyclase C activities and EC50 (concentration of ST yielding 50% of the maximum stimulation) values were extracted from nonlinear regression analyses employing sigmoidal dose-response curves of the Mg-GTP activity of guanylyl cyclase C in the presence of different concentrations of ST and in the absence or presence of 1 mM Ca2+. Values are the means ± S.E.M. of three experiments performed in duplicate, with each sample analyzed in triplicate.

 

View this table:
[in this window]
[in a new window]
 
TABLE 2 Calcium inhibits ST-stimulated guanylyl cyclase C by an uncompetitive kinetic mechanism

Vmax (maximum velocity) and S0.5 values (concentration of substrate yielding half-maximum velocity) were extracted from nonlinear regression analyses employing Michaelis-Menten kinetic plots of guanylyl cyclase activity stimulated by 1 µM ST in the presence of different concentrations of Mg-GTP and in the absence or presence of 1 mM Ca2+. Values are the means ± S.E.M. of three experiments performed in duplicate, with each sample analyzed in triplicate.

 


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 8. Ca2+ inhibits guanylyl cyclase C by competing with free Mg2+ for an allosteric cation-binding site. A, effect of Ca2+ on allosteric regulation by free Mg2+ of ST-stimulated guanylyl cyclase C. The activity of guanylyl cyclase C in T84 cell membranes was quantified in incubations containing 1 µM ST, 1 mM Mg-GTP, and 0.25 to 20 mM excess free Mg2+ in the absence ({blacksquare}) or presence ({blacktriangledown}) of 250 uM Ca2+. Data presented in A were subjected to double reciprocal analysis (B). Results represent ≥3 experiments performed in duplicate, with each sample analyzed in triplicate.

 

View this table:
[in this window]
[in a new window]
 
TABLE 3 Calcium inhibits ST-stimulated guanylyl cyclase C by competing with free Mg2+ for binding to an allosteric site

Maximum ST-induced guanylyl cyclase C activities and Ka (concentration of Mg2+ yielding 50% of the maximum activity) values were extracted from nonlinear regression analyses of the sigmoidal concentration-response curves of Mg2+-dependent guanylyl cyclase C activity in the absence or presence of 0.25 mM Ca2+. Values are means ± S.E.M. of three experiments performed in duplicate, with each sample analyzed in triplicate.

 


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Colorectal cancer is one of the leading causes of cancer death in developed countries (Ferlay et al., 2001Go). Neoplastic transformation in the colon partly reflects reduced expression of tumor suppressor genes such as guanylin and uroguanylin, which inhibit enterocyte proliferation by activating guanylyl cyclase C and increasing [cGMP]i (Cohen et al., 1998Go; Shailubhai et al., 2000Go; Pitari et al., 2001Go, 2003Go; Steinbrecher et al., 2002Go). Indeed, "replacement" of these endogenous hormones by longitudinal exposure to enterotoxigenic bacteria secreting ST may underlie the inverse epidemiological association between colorectal cancer (Ferlay et al., 2001Go) and ETEC infections (Prevention CfDCa, 2001Go). The present study revealed that guanylyl cyclase C is a conditional sensor of Ca2+ that allosterically inhibits ST-stimulated but not basal cGMP production. In cells, conditional inhibition of ST-stimulated guanylyl cyclase C is imposed by capacitative Ca2+ entry through SOCs, a key proliferative signaling mechanism generally (Golovina et al., 2001Go; Peng et al., 2003Go) and in colon cancer cells specifically (Weiss et al., 2001Go; Peng et al., 2003Go). Importantly, influx of extracellular Ca2+ through SOCs and the reciprocal inhibition of guanylyl cyclase C block the accumulation of [cGMP]i absolutely required for antiproliferative signaling by that receptor (Pitari et al., 2001Go, 2003Go). These observations support a model in which colorectal carcinogenesis, in part, reflects an imbalance between opposing cGMP- and Ca2+-mediated mechanisms in which antiproliferative signaling by guanylyl cyclase C is attenuated by reduced availability of endogenous ligands (Cohen et al., 1998Go; Shailubhai et al., 2000Go; Pitari et al., 2001Go, 2003Go; Steinbrecher et al., 2002Go; Bardelli et al., 2003Go) and increased inhibition by proliferative signaling through SOCs (Weiss et al., 2001Go; Peng et al., 2003Go). Moreover, they suggest that guanylyl cyclase C ligands, such as bacterial enterotoxins that exhibit exceptional specificity and potency (Hugues et al., 1991Go; Lucas et al., 2000Go), and inhibitors of SOCs represent a novel synergistic strategy for cGMP-directed therapy in patients with colorectal cancer.

Colon cancer cell proliferation is one example of a general paradigm in which Ca2+ and cGMP mediate opposing (patho)physiological processes reflected in the reciprocal regulation of their intracellular concentrations. The molecular mechanism by which Ca2+ directly regulates guanylyl cyclases and cGMP production has only recently been revealed (Andric et al., 2001Go; Kazerounian et al., 2002Go). Thus, nitric oxide-stimulated but not basal soluble guanylyl cyclase (sGC) is allo-sterically inhibited by direct binding of Ca2+ to high-(Ki = 10–8 M) and low-affinity (Ki = 10–5 M) binding sites (Kazerounian et al., 2002Go). Those with high affinity seem to be unique allosteric cation inhibitory sites. In contrast, those with low affinity are Mg2+-binding sites required for nitric oxide activation, and Ca2+ inhibits sGC at those sites by an uncompetitive kinetic mechanism in which Ca2+ antagonizes Mg2+ binding to those sites (Kazerounian et al., 2002Go). Similarly, the present study demonstrates that ST-stimulated but not basal guanylyl cyclase C is allosterically inhibited by Ca2+. Inhibition of guanylyl cyclase C is mediated by an uncompetitive kinetic mechanism in which Ca2+ antagonizes Mg2+ binding to sites with a Ki nearly identical to that of low-affinity sites of sGC (Kazerounian et al., 2002Go). Moreover, high- and low-affinity Ca2+-binding sites mediate allosteric inhibition of adenylyl cyclase types V and VI, and low-affinity sites exhibit kinetic characteristics that are nearly identical to those reported herein for guanylyl cyclase C (Guillou et al., 1999Go). Thus, allosteric inhibition by direct interaction of Ca2+ with nucleotide cyclases seems to be a generalized mechanism that coordinates the reciprocal regulation of intracellular concentrations of cyclic nucleotides and Ca2+ that mediate opposing physiological processes.

Guanylyl cyclases and cGMP are emerging as important regulators of proliferation, although the mechanisms that mediate that activity seem to be cell-specific. Cyclic GMP delays the G1/S transition in human vascular smooth muscle cells by decreasing cyclin D1 and cyclin-dependent kinase 4 activities following platelet-derived growth factor stimulation (Fukumoto et al., 1999Go). In addition, proliferation of glomerular mesangial cells by phorbol ester is blocked by cGMP-induced expression of the phosphatase MKP-1 (Sugimoto et al., 1996Go). In colorectal cancer cells, inhibition of proliferation is mediated by a signaling mechanism initiated by ligand interaction with guanylyl cyclase C (Shailubhai et al., 2000Go; Pitari et al., 2001Go, 2003Go). The resulting accumulation of [cGMP]i suppresses proliferation by opening CNG channels permitting the influx of extracellular Ca2+ (Pitari et al., 2003Go). Indeed, inhibition of human colon cancer cell proliferation by ST is reversed by L-cis-diltiazem and BAPTA-AM and requires Ca2+ in the media (Pitari et al., 2003Go).

Although extracellular Ca2+ is the downstream effector that inhibits proliferation by guanylyl cyclase C through CNG channels on the one hand and promotes proliferation and reciprocal inhibition of guanylyl cyclase C through SOCs on the other (Cole and Kohn, 1994Go; Berridge et al., 1998Go; Weiss et al., 2001Go; Peng et al., 2003Go), these opposing mechanisms represent discrete pathways for Ca2+ signaling. Thus, in human colon carcinoma cells, ST induces the influx of extracellular Ca2+ through cGMP-activated CNG channels, which produces elevations in [Ca2+]i that inhibit proliferation and open KCa channels in a concentration-dependent fashion (Pitari et al., 2003Go) but do not inhibit accumulation of [cGMP]i induced by ST, demonstrated herein. Indeed, in the absence of open SOCs, [Ca2+]ext up to 10 mM did not alter the accumulation of [cGMP]i induced by ST (see Results). These observations suggest that influx of extracellular Ca2+ into colon carcinoma cells through CNG channels is not coupled to allosteric inhibition of guanylyl cyclase C, in contrast to capacitative Ca2+ entry mediated by SOCs.

Divergent anti- and proproliferative Ca2+ signals through CNG and SOCs, respectively, may be resolved in human colon carcinoma cells through spatial organization and relative affinity. Guanylyl cyclase C in intestinal cells tightly associates with the brush-border cytoskeleton (Hakki et al., 1993Go) and may organize into signaling complexes with other molecules, including cGMP-dependent protein kinase and cystic fibrosis transmembrane conductance regulator, through postsynaptic density 95/disc-large/zona occludens domains (Scott et al., 2002Go). Moreover, guanylyl cyclase C possesses only low-affinity sites that mediate allosteric inhibition by Ca2+, in contrast to sGC, which possesses high- and low-affinity sites (Kazerounian et al., 2002Go). This combination of high- and low-affinity allosteric sites in sGC permits the regulation of [cGMP]i over the dynamic range of cytosolic [Ca2+]i that characterizes reciprocally regulated opposing processes such as contraction and relaxation in smooth muscle cells (Kazerounian et al., 2002Go). In contrast, the presence of low- but not high-affinity sites specifically permits guanylyl cyclase C to discriminate cytostatic Ca2+ signaling through CNG channels, which produce extremely small changes in [Ca2+]i (Pitari et al., 2003Go), from proliferative signaling by capacitative Ca2+ entry through SOCs, which can produce [Ca2+]i of ~10–5 M (Fig. 3, D and E) (Kerschbaum and Cahalan, 1999Go).

These considerations suggest a model wherein CNG channels may be extrinsic to guanylyl cyclase C-containing complexes but form complexes with other signaling molecules such as those that mediate cytostasis and KCa channels (Davare et al., 2001Go). The influx of extracellular Ca2+ through cGMP-activated CNG channels induces signaling by molecules within the complex but is insufficient (Pitari et al., 2003Go) to occupy low-affinity inhibitory sites on guanylyl cyclase C extrinsic to those complexes. In contrast, SOCs may form complexes with guanylyl cyclase C, and capacitative Ca2+ entry through those channels inhibits ST-induced [cGMP]i accumulation by binding to low-affinity allosteric sites facilitated by close proximity of molecules in the complex. The spatial organization of guanylyl cyclase C and cation channels in brush-border membranes and its role in signal discrimination await precise identification of the complement of SOCs expressed in human intestinal epithelial cells (Davare et al., 2001Go; Yue et al., 2001Go). In this regard, it is noteworthy that in intestinal cells a selective calcium entry channel, CaT1, which is a member of the transient receptor potential family with pore properties of SOCs, is localized in brush-border membranes (Davare et al., 2001Go; Yue et al., 2001Go) where guanylyl cyclase C resides (Hakki et al., 1993Go).

In summary, proliferative signaling mediated by capacitative Ca2+ entry through SOCs opposes signaling by guanylyl cyclase C and its downstream effector cGMP. Reciprocal regulation of these opposing signaling mechanisms is mediated in part by conditional allosteric inhibition of ligand-stimulated guanylyl cyclase C by Ca2+. The balance of proproliferative and antiproliferative signals mediated by Ca2+ and guanylyl cyclase C, respectively, may regulate the gradient of proliferation along the crypt-villus axis in normal intestine (Whitfield et al., 1995Go). Furthermore, an imbalance in these opposing mechanisms that involve attenuation of cGMP-dependent antiproliferative signaling may contribute to mechanisms that underlie colorectal carcinogenesis (Pitari et al., 2003Go). Importantly, the combination of bacterial enterotoxins that serves as super agonists of guanylyl cyclase C (Pitari et al., 2001Go, 2003Go) and specific inhibitors of SOCs offers a novel paradigm for cGMP-directed therapy for the treatment and prevention of colorectal tumors.


    Footnotes
 
This study was supported by National Institutes of Health Grants HL59214, CA75123, CA79663, and CA95026 (to S.A.W.); GM59419 (to G.H.); the Landenberger Foundation (to G.M.P.); and Targeted Diagnostics and Therapeutics, Inc. I.R.-S. was supported by National Institutes of Health Minority Supplement HL59214-0151. G.S.F. was enrolled in the National Institutes of Health Institutional K30 Training Program in Human Investigation (K30 HL004522) and was supported by National Institutes of Health Institutional Award T32 GM08562 for Postdoctoral Training in Clinical Pharmacology. S.A.W. is the Samuel M. V. Hamilton Professor of Medicine of Thomas Jefferson University.

doi:10.1124/jpet.105.089052.

ABBREVIATIONS: ETEC, enterotoxigenic E. coli; ST, heat-stable enterotoxin; CNG, cyclic nucleotide-gated; SOC, store-operated calcium channel; BAPTA, 1,2-bis(o-amino-5,5'-dibromophenoxy)ethane-N,N,N',N'-tetraacetic acid; AM, acetoxymethyl ester; 2-APB, 2-aminoethoxydiphenylborate; IBMX, isobutylmethylxanthine; sGC, soluble guanylyl cyclase.

Address correspondence to: Dr. Scott A. Waldman, Division of Clinical Pharmacology, Thomas Jefferson University, 132 S. 10th St., 1170 Main, Philadelphia, PA 19107. E-mail: scott.waldman{at}jefferson.edu


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

Andric SA, Kostic TS, Tomic M, Koshimizu T, and Stojilkovic SS (2001) Dependence of soluble guanylyl cyclase activity on calcium signaling in pituitary cells. J Biol Chem 276: 844–849.[Abstract/Free Full Text]

Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S, Markowitz S, Willson JK, Parmigiani G, Kinzler KW, et al. (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science (Wash DC) 300: 949.[Free Full Text]

Berridge MJ, Bootman MD, and Lipp P (1998) Calcium–a life and death signal. Nature (Lond) 395: 645–648.[CrossRef][Medline]

Bootman MD, Collins TJ, Mackenzie L, Roderick HL, Berridge MJ, and Peppiatt CM (2002) 2-Aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB J 16: 1145–1150.[Abstract/Free Full Text]

Cohen MB, Hawkins JA, and Witte DP (1998) Guanylin mRNA expression in human intestine and colorectal adenocarcinoma. Lab Investig 78: 101–108.[Medline]

Cole K and Kohn E (1994) Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metastasis Rev 13: 31–44.[CrossRef][Medline]

Csordas G and Hajnoczky G (2001) Sorting of calcium signals at the junctions of endoplasmic reticulum and mitochondria. Cell Calcium 29: 249–262.[CrossRef][Medline]

Davare MA, Avdonin V, Hall DD, Peden EM, Burette A, Weinberg RJ, Horne MC, Hoshi T, and Hell JW (2001) A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2. Science (Wash DC) 293: 98–101.[Abstract/Free Full Text]

Ferlay J, Bray F, Pisani P, and Parkin DM (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. International Agency for Research on Cancer (IARC) CancerBase no. 5. Lyon, France: IARC, 2001.

Fukumoto S, Koyama H, Hosoi M, Yamakawa K, Tanaka S, Morii H, and Nishizawa Y (1999) Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. Circ Res 85: 985–991.[Abstract/Free Full Text]

Golovina VA, Platoshyn O, Bailey CL, Wang J, Limsuwan A, Sweeney M, Rubin LJ, and Yuan JX (2001) Up-regulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation. Am J Physiol 280: H746–H755.

Guillou JL, Nakata H, and Cooper DM (1999) Inhibition by calcium of mammalian adenylyl cyclases. J Biol Chem 274: 35539–35545.[Abstract/Free Full Text]

Hakki S, Crane M, Hugues M, O'Hanley P, and Waldman SA (1993) Solubilization and characterization of functionally coupled Escherichia coli heat-stable toxin receptors and particulate guanylate cyclase associated with the cytoskeleton compartment of intestinal membranes. Int J Biochem 25: 557–566.[CrossRef][Medline]

Holmuhamedov E, Lewis L, Bienengraeber M, Holmuhamedova M, Jahangir A, and Terzic A (2002) Suppression of human tumor cell proliferation through mitochondrial targeting. FASEB J 16: 1010–1016.[Abstract/Free Full Text]

Hugues M, Crane M, Hakki S, O'Hanley P, and Waldman SA (1991) Identification and characterization of a new family of high-affinity receptors for Escherichia coli heat-stable enterotoxin in rat intestinal membranes. Biochemistry 30: 10738–10745.[CrossRef][Medline]

Kazerounian S, Pitari GM, Ruiz-Stewart I, Schulz S, and Waldman SA (2002) Nitric oxide activation of soluble guanylyl cyclase reveals high and low affinity sites that mediate allosteric inhibition by calcium. Biochemistry 41: 3396–3404.[CrossRef][Medline]

Kerschbaum HH and Cahalan MD (1999) Single-channel recording of a store-operated Ca2+ channel in Jurkat T lymphocytes. Science (Wash DC) 283: 836–839.[Abstract/Free Full Text]

Liu C and Hermann TE (1978) Characterization of ionomycin as a calcium ionophore. J Biol Chem 253: 5892–5894.[Abstract/Free Full Text]

Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, and Waldman SA (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52: 375–414.[Abstract/Free Full Text]

Luo D, Broad LM, Bird GS, and Putney JW Jr (2001) Signaling pathways underlying muscarinic receptor-induced [Ca2+]i oscillations in HEK293 cells. J Biol Chem 276: 5613–5621.[Abstract/Free Full Text]

Ma HT, Patterson RL, van Rossum DB, Birnbaumer L, Mikoshiba K, and Gill DL (2000) Requirement of the inositol trisphosphate receptor for activation of store-operated Ca2+ channels. Science (Wash DC) 287: 1647–1651.[Abstract/Free Full Text]

Parekh AB and Penner R (1997) Store depletion and calcium influx. Physiol Rev 77: 901–930.[Abstract/Free Full Text]

Parkinson SJ and Waldman SA (1996) An intracellular adenine nucleotide binding site inhibits guanyly cyclase C by a guanine nucleotide-dependent mechanism. Biochemistry 35: 3213–3221.[CrossRef][Medline]

Peng JB, Brown EM, and Hediger MA (2003) Epithelial Ca2+ entry channels: transcellular Ca2+ transport and beyond. J Physiol 551: 729–740.[Abstract/Free Full Text]

Pitari GM, Di Guglielmo MD, Park J, Schulz S, and Waldman SA (2001) Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc Natl Acad Sci USA 98: 7846–7851.[Abstract/Free Full Text]

Pitari GM, Zingman LV, Hodgson DM, Alekseev AE, Kazerounian S, Bienengraeber M, Hajnoczky G, Terzic A, and Waldman SA (2003) Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci USA 100: 2695–2699.[Abstract/Free Full Text]

Prevention CfDCa (2001) Health Information for International Travel. 1999–2000, Department of Health and Human Services, Atlanta, GA. Center for Disease Control and Prevention, Atlanta.

Rink TJ and Merritt JE (1990) Calcium signalling. Curr Opin Cell Biol 2: 198–205.[CrossRef][Medline]

Sargeant P and Sage SO (1994) Calcium signalling in platelets and other nonexcitable cells. Pharmacol Ther 64: 395–443.[CrossRef][Medline]

Scott RO, Thelin WR, and Milgram SL (2002) A novel PDZ protein regulates the activity of guanylyl cyclase C, the heat-stable enterotoxin receptor. J Biol Chem 277: 22934–22941.[Abstract/Free Full Text]

Shailubhai K, Yu HH, Karunanandaa K, Wang JY, Eber SL, Wang Y, Joo NS, Kim HD, Miedema BW, Abbas SZ, et al. (2000) Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res 60: 5151–5157.[Abstract/Free Full Text]

Steinbrecher KA, Wowk SA, Rudolph JA, Witte DP, and Cohen MB (2002) Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation. Am J Pathol 161: 2169–2178.[Abstract/Free Full Text]

Sugimoto T, Haneda M, Togawa M, Isono M, Shikano T, Araki S, Nakagawa T, Kashiwagi A, Guan KL, and Kikkawa R (1996) Atrial natriuretic peptide induces the expression of MKP-1, a mitogen-activated protein kinase phosphatase, in glomerular mesangial cells. J Biol Chem 271: 544–547.[Abstract/Free Full Text]

Szalai G, Krishnamurthy R, and Hajnoczky G (1999) Apoptosis driven by IP(3)-linked mitochondrial calcium signals. EMBO (Eur Mol Biol Organ) J 18: 6349–6361.[CrossRef][Medline]

Thastrup O, Dawson AP, Scharff O, Foder B, Cullen PJ, Drobak BK, Bjerrum PJ, Christensen SB, and Hanley MR (1989) Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions 27: 17–23.[CrossRef][Medline]

Thielman NM and Guerrant RL (2004) Acute infectious diarrhea. N Engl J Med 350: 38–47.[Free Full Text]

Weiss H, Amberger A, Widschwendter M, Margreiter R, Ofner D, and Dietl P (2001) Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of nonsteroidal anti-inflammatory drugs in human colon cancer cells. Int J Cancer 92: 877–882.[CrossRef][Medline]

Welberg JW, Kleibeuker JH, Van der Meer R, Kuipers F, Cats A, Van Rijsbergen H, Termont DS, Boersma-van Ek W, Vonk RJ, Mulder NH, et al. (1993) Effects of oral calcium supplementation on intestinal bile acids and cytolytic activity of fecal water in patients with adenomatous polyps of the colon. Eur J Clin Investig 23: 63–68.[Medline]

Whitfield JF, Bird RP, Chakravarthy BR, Isaacs RJ, and Morley P (1995) Calcium-cell cycle regulator, differentiator, killer, chemopreventor and maybe, tumor promoter. J Cell Biochem Suppl 22: 74–91.

Yue L, Peng JB, Hediger MA, and Clapham DE (2001) CaT1 manifests the pore properties of the calcium-release-activated calcium channel. Nature (Lond) 410: 705–709.[CrossRef][Medline]


This article has been cited by other articles:


Home page
CarcinogenesisHome page
G. M. Pitari, J. E. Lin, F. J. Shah, W. J. Lubbe, D. S. Zuzga, P. Li, S. Schulz, and S. A. Waldman
Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells
Carcinogenesis, August 1, 2008; 29(8): 1601 - 1607.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Fedida-Metula, S. Elhyany, S. Tsory, S. Segal, M. Hershfinkel, I. Sekler, and D. Fishman
Targeting lipid rafts inhibits protein kinase B by disrupting calcium homeostasis and attenuates malignant properties of melanoma cells
Carcinogenesis, August 1, 2008; 29(8): 1546 - 1554.
[Abstract] [Full Text] [PDF]